HOUSTON, Oct. 23, 2019 /PRNewswire/ -- Nova Medical Centers, the nation's leading pure occupational medicine provider, announced today that Dr. Samantha Toews, PT, DPT. has been named as its Vice President of Center Operations.

ROCK HILL, S.C. and LEUVEN, Belgium, Oct. 23, 2019 /PRNewswire/ -- Today,

RALEIGH, N.C., Oct. 23, 2019 /PRNewswire/ -- Kineticos Life Sciences announces the further expansion of their senior leadership team with the addition of Dan McCormick, Senior Vice President, Biopharma Practice. 

NEW YORK, Oct. 23 2019 /PRNewswire/ -- Researchers report that both fluoride and aluminum (Al3+), individually, are poisonous to the nervous system. Toget

TAMPA, Fla., Oct. 23, 2019 /PRNewswire/ -- iCare Health Solutions, LLC (iCare) has announced that its Diabetic Retinal Exam (DRE) patient outreach program has helped five of its Florida-based Medicare Advantage partners earn the CMS Five-Star rating for their Healthcare Effectiveness Data and Information Set (HEDIS) Diabetic Retinal

WILMINGTON, Del., Oct. 23, 2019 /PRNewswire/ -- NeuroRx, Inc (NeuroRx) announced that it has signed an agreement with GEM Global Yield LLC SCS ("GEM"), the New York based private alternative investment group to provide the NeuroRx with up to HK$ 750 million over a 30 month term following a public

EGG HARBOR TOWNSHIP, N.J., Oct. 23, 2019 /PRNewswire/ -- New research on the experiences of intimate partner abuse survivors in therapy reveals that counselors who tell clients they are "codependent" or "chose the relationship" may be offending them and delivering harmful therapy. But counselors who understand antisocial personality disorder and psychopathy can effe

NEW YORK, Oct. 23, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "When it comes to the best possible financial compensation for

VANCOUVER, Oct. 23, 2019 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ("CRH" or the "Company") today announced that it has entered into a new, three year revolving credit facility (the "new facility"), which provides up to $200 million in borrowing capacity, and represents an increase from the company's previous

EMERYVILLE, Calif., Oct. 23, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2019 after market close on Thursday, November 7, 2019.